Monday, March 28, 2016

Bayer to organize relief measures to rehabilitate rural Chennai population

The city of Chennai and the State of Tamil Nadu were ravaged by floods and incessant rains in the last quarter of 2015. According to estimates, the unprecedented damage caused by them left more than 347 people dead and 1.8 million displaced. According to a report published by  Aon Benfield, UK, the floods in Chennai are amongst the eight-most expensive natural disasters in the world in 2015, and have had an impact of more than Rs.20,000 crores (US$3 billion) in losses to the Indian economy.

Bayer India has committed Euro 100,000 (approx. INR 8,500,000) to help alleviate the suffering of these flood victims. Working in close collaboration with the reputed NGO, Concern India Foundation, Bayer is working on a more long term assistance to these flood victims. Concern India Foundation (CIF) is a registered non-profit charitable trust working towards helping people help themselves. Set up in 1991, CIF works in the areas of Education, Health and Community Development.

As a first step, representatives from Concern India Foundation visited the flood affected areas in the beginning of 2016. Through initial visits to the flood affected areas, community meetings, school staff and organization visits, the team has come up with a set of relief measures for improving conditions in  urban and semi-urban areas.

Speaking about the disaster relief, Richard van der Merwe, Senior Bayer Representative, South Asia said “To provide targeted assistance to people who find themselves in situations of acute need as a result of natural disasters, Bayer pursues a dual strategy: the company provides immediate assistance following natural disasters – both through monetary and medical donations and through donations in kind to rebuild infrastructure. In this case, we have found through our initial study that relief is the need of the hour for rural areas adjoining the city of Chennai especially Kanchipuram located 60 kms away from the city. The principle focus areas of our rehabilitation would center on providing healthcare and help victims get back to their earlier livelihood as soon as possible.”

The objectives of the relief measures will aim to provide health care to prevent severe morbidity issues, ensure clean and hygienic drinking water source to prevent health issues and work on increasing health awareness and sanitation with the community for safe childhood and motherhood. A number of health camps, installation of Reverse Osmosis water purification plants, are a part of Bayer’s relief program.

Disaster aid is a component of Bayer’s social responsibility commitment. The company provides rapid assistance without red tape in many emergency situations around the world.

Bayer: Science For A Better Life

Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fiscal 2015, the Group employed around 117,000 people and had sales of EUR 46.3 billion. Capital expenditures amounted to EUR 2.6 billion, R&D expenses to EUR 4.3 billion. These figures include those for the high-tech polymers business, which was floated on the stock market as an independent company named Covestro on October 6, 2015. For more information, go to


Media Contacts:
Aloke Pradhan
Corporate Communications, Bayer Group in India
Phone: +91 22 2531 1090 | Email:

Forward-Looking Statements: This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments. 


Copyright © Bayer AG